TABLE 1 Baseline characteristics
ControlsCOPD
NonsmokingSmokingGOLD 2GOLD 3GOLD 4
Subjects n4618317918660
Age years61±853±862±764±764±6
Height cm173±9172±9171±8170±9171±8
Weight kg78±1378±1476±1874±1869±19
BMI kg·m−226±326±426±525±524±5
Smoking pack-years  median (IQR)27 (17–39)35 (23–50)37 (24–50)38 (25–55)
PaO2#kPa10.7±1.110.8±1.29.6±1.19.2±1.08.6±1.1
6MWD# m462±93414±105338±128
Symptoms mean (IQR)
mMRC# dyspnoea scale  score0.1 (0–0)0.2 (0–0)1.1 (0–2)1.7 (1–2)2.3 (1.75–3)
 SGRQ-C# score3 (0–5)5 (2–9)34 (19–51)44 (30–59)56 (49–68)
Spirometry
 FEV1 L3.3±0.73.4±0.71.9±0.41.3±0.30.8±0.2
 FEV1 % pred100±1097±960±640±525±4
 FVC L4.1±0.94.4±0.93.6±0.93.2±0.92.6±0.8
Plethysmography
 TLC# L6.5±1.36.5±1.37.0±1.47.2±1.47.8±1.3
 IC# L3.3±0.83.3±0.82.8±0.82.4±0.72.0±0.6
 RV# L2.1±0.51.8±0.62.8±0.93.4±0.94.5±1.0
  • Data are presented as mean±sd, unless otherwise stated. n=654. COPD: chronic obstructive pulmonary disease; GOLD: Global Initiative for Chronic Obstructive Lung Disease; BMI: body mass index; IQR: interquartile range; PaO2: arterial oxygen tension; 6MWD: 6-min walking distance; mMRC: modified Medical Research Council; SGRQ-C: St George’s Respiratory Questionnaire for COPD patients; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity; TLC: total lung capacity; IC: inspiratory capacity; RV: residual volume. #: analysis restricted to patients with complete data.